SDSemaglutide Dosage

Medical Reviewer — Semaglutide Dosage

Audrey Poliran Baysa, RPh, MSc — registered pharmacist and medical reviewer for Semaglutide Dosage, photographed in a community pharmacy in Davao City, Philippines
Audrey P. Baysa, RPh, MSc — on duty at her pharmacy in Davao City.

Audrey P. Baysa, RPh, MSc

Registered Pharmacist

Full legal name: Baysa, Audrey Poliran · Registered Pharmacist (Philippines) · MSc · Philippine Pharmacists Association – Davao City Chapter

✅ PRC-verified via verification.prc.gov.ph (Professional Regulation Commission, Republic of the Philippines).

Audrey P. Baysa is a Philippine-registered pharmacist (RPh) with a Master of Science (MSc) and a track record of professional leadership within the Philippine Pharmacists Association. She has served as Chairperson of the Community Extension Committee for the PPhA – Davao City Chapter, where her work has centered on community-health pharmacy practice and patient education.

Her clinical focus includes metabolic and endocrine medications, with particular attention to GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) and the oral formulation (Rybelsus). Day-to-day, Audrey counsels patients navigating titration, troubleshoots side effects, and fields the "what if I missed my shot?" questions that don't fit neatly into a short clinic visit. Her philosophy: a patient who understands why a dose steps up every four weeks is a patient who actually completes titration safely.

Audrey reviews every tool, dosage chart, and article on Semaglutide Dosage before publication, and re-reviews evergreen content at least every six months. She flags changes in FDA prescribing information, new trial data, and real-world issues patients raise. Her edits are unhedged: if a sentence is clinically wrong, it gets rewritten; if a calculation is off by a decimal, it gets fixed the same day.

Outside of reviewing content for Semaglutide Dosage, Audrey continues her community-extension work with the PPhA Davao City Chapter and contributes to patient-education materials for the pharmacy practice she supports. She believes plain-language medical writing is a public-health intervention, not a copywriting exercise.

Verify on PRC →

Review process

  1. Every page is drafted by our editorial team citing FDA-approved prescribing information and primary trial data.
  2. Audrey reviews for clinical accuracy, completeness, and plain-language clarity, flagging anything that could be misread as a personalized recommendation.
  3. Factual corrections are applied before publication. Style and voice suggestions are applied at the editor's discretion.
  4. Every dosage page is re-reviewed at least every six months or whenever an FDA label is updated, whichever is sooner.
  5. A dated review notice ("Last reviewed on…") appears on every page. Substantive revisions are logged in the site's editorial policy.

Not a personal care relationship. Audrey's review does not constitute medical advice, a prescription, or a care relationship with any reader. For personalized dosing, see your own prescriber or pharmacist.